Is physical activity safe and beneficial for patients with juvenile idiopathic arthritis?

Authors: Emanuela Doroftei2, Ileana Monica Borda1,2, László Irsay12, Viorela Ciortea1,2, Alexandrina Nicu2, Călina Ciubotariu2, Rodica Ana Ungur1,2

 

Affiliation

1 “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Department of Medical

  Rehabilitation within the Rehabilitation Hospital, Cluj-Napoca, Romania

2 Clinical Rehabilitation Hospital Cluj-Napoca, Romania

 

Abstract

Juvenile idiopathic arthritis is one of the most common physically disabling conditions of childhood and its cause is unknown. Untreated, the disease has a natural oscillating evolution, with exacerbations and periods of low activity and, less frequently, episodes of spontaneous remission. Over time, the disease affects the body’s functionality and greatly reduces its adaptation to the environment and quality of life.

The treatment used addresses both symptoms and structural and functional changes so that, along with anti-inflammatory and disease-modifying substances (synthetic or biological), regular physical exercise can be a form of prophylactic treatment of long-term complications.

In this regard, we set out to review a series of articles to highlight the impact of physical activity on children affected by juvenile idiopathic arthritis. Physical activity has been shown to have an impact not only on functional capacity, but also on a cellular level, with the final result of reducing inflammation and promoting a healthier intestinal environment by diversifying the intestinal microbiome.

In conclusion, physical activity is safe for children with juvenile idiopathic arthritis. Keeping a physical activity regimen brings benefits both at the systemic level, through cellular mediation, and at the musculoskeletal level.

 

Key words:  juvenile idiopathic arthritis, physical activity, functionality, quality of life, cellular impact, impact on intestinal microbiome.

07-doroftei115-119

Is physical activity safe and beneficial for patients with juvenile idiopathic arthritis?

https://doi.org/10.26659/pm3.2021.22.2.115